Beyond labeling: differential Ac4ManNAz dosing as a tool for functional manipulation of mesenchymal stem cells
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 09.03.2026. Verfasst von Xueying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical School of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregenera…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Laboratory of Neuroregeneration of Jiangsu and the Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University.
Abstract (Originalsprache)
Bioorthogonal chemistry technology serves as a powerful tool for mesenchymal stem cell (MSC) transplantation by utilizing metabolic engineering for direct cell modification either in vivo or in vitro. However, the unclear effects of varying concentrations of non-natural metabolic monosaccharides on labeling efficiency, functional impact and safety pose significant challenges for clinical translation. Herein, we screened the concentration-dependent effects of the metabolic labeling agent Ac4ManNAz (10–100 µM) on the functionality of MSC. Visualizing azido groups on the cell surface through bioorthogonal reactions confirmed that labeling efficiency positively correlated with the concentration of Ac4ManNAz. Interestingly, treatment of MSC with 50-µM Ac4ManNAz enhances their immune regulatory function. Mechanistically, 50-µM Ac4ManNAz remodels the extracellular matrix of MSC by downregulating decorin (DCN) expression to alleviate TGF-β inhibition, simultaneously upregulating serglycin (SRGN) expression to activate and stabilize TGF-β. This dual action results in increased secretion of TGF-β, thereby augmenting the immune regulatory capacity of MSC. Nevertheless, at the level of cellular motility, treatment with 50-µM Ac4ManNAz significantly impairs the migratory capacity of MSC. Overall, this study clearly defined the concentration effect of non-natural monosaccharides on MSC biological functionality for clinical applications of this technology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School of Nantong University, Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, Nantong University, 19 Qixiu Road, Chongchuan District, Nantong,…
- The Third Clinical Medical College, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, No. 100 Cross Street, Hongshan Road, Qixia District, Nanjing, Jiang…
Förderung
- National Natural Science Foundation of China
- Key Laboratory of Neuroregeneration of Jiangsu and the Ministry of Education
- Co-Innovation Center of Neuroregeneration, Nantong University
Zitieren
APA
Zhao, X., Li, S., Jiang, X., Ma, Y., Fan, K., Zhang, L., Liu, X., & Yang, Y. (2026). Beyond labeling: differential Ac4ManNAz dosing as a tool for functional manipulation of mesenchymal stem cells. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag044
Vancouver
Zhao X, Li S, Jiang X, Ma Y, Fan K, Zhang L, et al. Beyond labeling: differential Ac4ManNAz dosing as a tool for functional manipulation of mesenchymal stem cells. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag044
BibTeX
@article{Zhao2026,
author = {Zhao, Xueying and Li, Suqing and Jiang, Xingyu and Ma, Yuyang and Fan, Kewei and Zhang, Luzhong and Liu, Xin and Yang, Yumin},
title = {Beyond labeling: differential Ac4ManNAz dosing as a tool for functional manipulation of mesenchymal stem cells},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag044}
}
EUVIMED